From: Clinical and biochemical characterization of four patients with mutations in ECHS1
Acyl-carnitines | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Reference range |
---|---|---|---|---|---|
nmol/(96 hr.mg) | nmol/(96 hr.mg) | nmol/(96 hr.mg) | nmol/(96 hr.mg) | nmol/(96 hr.mg) | |
[U-13C] C2 | 16.75 | 11.01 | 21.49 | 19.88 | 2.3–43.3 |
C3 | 0.42 | 0.10 | 0.11 | 0 | 0–2.3 |
[U-13C] C4 | 1.06 | 0.31 | 0.43 | 0.93 | 0–2.0 |
C5 | 0.57 | 0.20 | 0.00 | 0 | 0–2.5 |
[U-13C] C6 | 0.31 | 0.15 | 0.26 | 0.78 | 0–1.4 |
[U-13C] C8 | 0.31 | 0.20 | 0.47 | 0.82 | 0.1–2.6 |
[U-13C] C10 | 0.31 | 0.26 | 0.79 | 0.73 | 0.2–3.1 |
[U-13C] C12 | 0.09 | 0.04 | 0.14 | 0.08 | 0–0.8 |
[U-13C] C14 | 0.05 | 0.09 | 0.05 | 0.04 | 0–0.4 |
[U-13C] C16 | 1.58 | 0.64 | 1.04 | 2.75 | 0–4.3 |
C16/C2 ratio | 0.10 | 0.06 | 0.05 | 0.14 | 0–0.32 |